Next Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $98K | Buy |
1,113
+58
| +5% | +$5.11K | 0.01% | 1173 |
|
|
2021
Q3 | $81K | Buy |
1,055
+28
| +3% | +$2.15K | 0.01% | 1207 |
|
|
2021
Q2 | $85K | Buy |
1,027
+11
| +1% | +$910 | 0.01% | 1188 |
|
|
2021
Q1 | $77K | Buy |
+1,016
| New | +$77K | 0.01% | 1117 |
|
|
2020
Q2 | – | Sell |
-200
| Closed | -$17K | – | 757 |
|
|
2020
Q1 | $17K | Hold |
200
| – | – | ﹤0.01% | 1332 |
|
|
2019
Q4 | $17K | Hold |
200
| – | – | ﹤0.01% | 1578 |
|
|
2019
Q3 | $13K | Hold |
200
| – | – | ﹤0.01% | 1597 |
|
|
2019
Q2 | $17K | Buy |
+200
| New | +$17K | ﹤0.01% | 1513 |
|
|
2019
Q1 | – | Sell |
-132
| Closed | -$11K | – | 1670 |
|
|
2018
Q4 | $11K | Sell |
132
-293
| -69% | -$24.4K | ﹤0.01% | 1297 |
|
|
2018
Q3 | $41K | Buy |
+425
| New | +$41K | 0.02% | 588 |
|
|
2017
Q4 | – | Sell |
-1,740
| Closed | -$166K | – | 386 |
|
|
2017
Q3 | $166K | Sell |
1,740
-1,285
| -42% | -$123K | 0.05% | 361 |
|
|
2017
Q2 | $275K | Sell |
3,025
-25
| -0.8% | -$2.27K | 0.07% | 281 |
|
|
2017
Q1 | $292K | Sell |
3,050
-275
| -8% | -$26.3K | 0.08% | 241 |
|
|
2016
Q4 | $275K | Buy |
3,325
+350
| +12% | +$28.9K | 0.05% | 373 |
|
|
2016
Q3 | $275K | Buy |
2,975
+995
| +50% | +$92K | 0.05% | 372 |
|
|
2016
Q2 | $154K | Buy |
1,980
+1,405
| +244% | +$109K | 0.05% | 358 |
|
|
2016
Q1 | $47K | Buy |
575
+375
| +188% | +$30.7K | 0.02% | 640 |
|
|
2015
Q4 | $20K | Hold |
200
| – | – | 0.01% | 910 |
|
|
2015
Q3 | $21K | Hold |
200
| – | – | 0.01% | 926 |
|
|
2015
Q2 | $27K | Hold |
200
| – | – | 0.01% | 876 |
|
|
2015
Q1 | $24K | Buy |
200
+50
| +33% | +$6K | 0.01% | 918 |
|
|
2014
Q4 | $14K | Sell |
150
-50
| -25% | -$4.67K | ﹤0.01% | 1115 |
|
|
2014
Q3 | $14K | Sell |
200
-68
| -25% | -$4.76K | ﹤0.01% | 1593 |
|
|
2014
Q2 | $17K | Buy |
+268
| New | +$17K | 0.01% | 641 |
|